Chipscreen(SH:688321) Shang Hai Zheng Quan Bao·2025-07-03 19:18Core Viewpoint - Shenzhen Micu Biotechnology Co., Ltd. experienced a significant stock price fluctuation, with a cumulative closing price increase of 30% over three consecutive trading days from July 1 to July 3, 2025, which is classified as abnormal trading activity according to relevant regulations [2][4]. Group 1: Stock Trading Abnormality - The company's stock price increased by a cumulative 30% over three trading days, indicating abnormal trading activity [2][4]. - The company has conducted a self-examination and confirmed that there are no undisclosed significant information affecting the stock price [5][6]. Group 2: Company Operations and Information Disclosure - The company's production and operational activities are normal, with no significant changes in market conditions, industry policies, or production costs [5]. - There are no undisclosed major events such as mergers, acquisitions, or restructuring that could impact the company's stock price [6][7]. - The company has not identified any media reports or market rumors that could have significantly influenced its stock price [7]. Group 3: Board of Directors' Statement - The Board of Directors confirms that there are no undisclosed matters that should be reported according to the relevant regulations [9]. - The company emphasizes the importance of timely and accurate information disclosure to assist investors in making informed decisions [10].